In a small study, the researchers tracked 30 men with low-risk prostate cancer who decided against conventional medical treatment such as surgery and radiation or hormone therapy.

The drug works by temporarily disrupting gonad function in men, and is used to treat prostate cancer.

Men with a high risk of prostate cancer recurrence could live longer if hormone treatment is given alongside radiotherapy after surgery, a new study has suggested.